Early targeted DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in different stages of impaired glucose homeostasis Cardiovascular Diabetology
暂无分享,去创建一个
G. Paolisso | L. Sommese | T. Infante | R. Marfella | M. Franzese | Mario Zanfardino | O. Affinito | C. Schiano | M. Miceli | C. Sardu | G. Mansueto | G. Benincasa | G. F. Nicoletti | C. Napoli | N. D. Mura | M. Salvatore | Marco Luongo | Marco Salvatore
[1] C. Napoli,et al. Clinical Role of Epigenetics and Network Analysis in Eye Diseases: A Translational Science Review , 2019, Journal of ophthalmology.
[2] N. Xia,et al. Pathologic T-cell response in ischaemic failing hearts elucidated by T-cell receptor sequencing and phenotypic characterization. , 2019, European heart journal.
[3] C. Napoli,et al. Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients , 2019, European heart journal. Cardiovascular pharmacotherapy.
[4] C. Napoli,et al. Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora’s box? , 2019, Journal of Clinical Pathology.
[5] C. Napoli,et al. Perturbation of interactome through micro-RNA and methylome analysis in diabetes endophenotypes: the PIRAMIDE pathogenic clinical study design , 2019, International Journal of Clinical Trials.
[6] Filippo Cademartiri,et al. Correlation of Circulating miR-765, miR-93-5p, and miR-433-3p to Obstructive Coronary Heart Disease Evaluated by Cardiac Computed Tomography. , 2019, The American journal of cardiology.
[7] M. Pesce,et al. Abnormal DNA Methylation Induced by Hyperglycemia Reduces CXCR4 Gene Expression in CD34+ Stem Cells , 2019, Journal of the American Heart Association.
[8] Filippo Cademartiri,et al. Evidence of association of circulating epigenetic-sensitive biomarkers with suspected coronary heart disease evaluated by Cardiac Computed Tomography , 2019, PloS one.
[9] John L. Campbell,et al. Type 1 diabetes impairs the mobilisation of highly-differentiated CD8+T cells during a single bout of acute exercise. , 2019, Exercise immunology review.
[10] Disclosures: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[11] A. Soricelli,et al. Epigenetic Hallmarks of Fetal Early Atherosclerotic Lesions in Humans , 2018, JAMA cardiology.
[12] C. Napoli,et al. Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes. , 2018, Journal of diabetes and its complications.
[13] M. Pirooznia,et al. Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism , 2018, Nature Communications.
[14] T. Spector,et al. Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus , 2018, Scientific Reports.
[15] Yuan-Lin Guo,et al. Impacts of Prediabetes Mellitus Alone or Plus Hypertension on the Coronary Severity and Cardiovascular Outcomes , 2018, Hypertension.
[16] Andrew P Feinberg,et al. The Key Role of Epigenetics in Human Disease Prevention and Mitigation. , 2018, The New England journal of medicine.
[17] Sang-Mo Kwon,et al. Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis , 2018, International journal of molecular sciences.
[18] Manolis Kellis,et al. Chromatin-state discovery and genome annotation with ChromHMM , 2017, Nature Protocols.
[19] M. Pelizzola,et al. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells , 2017, Oncogene.
[20] L. Liang,et al. Genome-Wide Analysis of DNA Methylation and Acute Coronary Syndrome , 2017, Circulation research.
[21] A. Ciccodicola,et al. Heart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing. , 2017, Cardiology journal.
[22] F. Gong,et al. Associations between FGF21, osteonectin and bone turnover markers in type 2 diabetic patients with albuminuria. , 2017, Journal of diabetes and its complications.
[23] A. Soricelli,et al. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus , 2017, Epigenetics.
[24] J. Zierath,et al. Insulin and Glucose Alter Death-Associated Protein Kinase 3 (DAPK3) DNA Methylation in Human Skeletal Muscle , 2016, Diabetes.
[25] Naveed Sattar,et al. The changing face of diabetes complications. , 2016, The lancet. Diabetes & endocrinology.
[26] Hedi Peterson,et al. g:Profiler—a web server for functional interpretation of gene lists (2016 update) , 2016, Nucleic Acids Res..
[27] Qing-Yu He,et al. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..
[28] M. Rots,et al. Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase , 2015, Epigenetics.
[29] F. Tang,et al. Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing , 2015, Nature Protocols.
[30] C. Ling,et al. Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes , 2014, Diabetes.
[31] M. Kivimäki,et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study , 2014, The lancet. Diabetes & endocrinology.
[32] Hemant K. Tiwari,et al. Epigenome-Wide Association Study of Fasting Measures of Glucose, Insulin, and HOMA-IR in the Genetics of Lipid Lowering Drugs and Diet Network Study , 2014, Diabetes.
[33] C. Ballantyne,et al. Elevated Plasma SPARC Levels Are Associated with Insulin Resistance, Dyslipidemia, and Inflammation in Gestational Diabetes Mellitus , 2013, PloS one.
[34] S. Akhtar,et al. The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction. , 2013, BioImpacts : BI.
[35] Brent S. Pedersen,et al. Comb-p: software for combining, analyzing, grouping and correcting spatially correlated P-values , 2012, Bioinform..
[36] Francine E. Garrett-Bakelman,et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles , 2012, Genome Biology.
[37] C. Napoli,et al. Maternal Immunization Affects In Utero Programming of Insulin Resistance and Type 2 Diabetes , 2012, PloS one.
[38] Peter A. Jones. Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.
[39] Andrea Soricelli,et al. Primary Prevention of Atherosclerosis: A Clinical Challenge for the Reversal of Epigenetic Mechanisms? , 2012, Circulation.
[40] C. Ling,et al. Increased DNA Methylation and Decreased Expression of PDX-1 in Pancreatic Islets from Patients with Type 2 Diabetes. , 2012 .
[41] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[42] C. Napoli,et al. Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage. , 2011, Cardiovascular research.
[43] Felix Krueger,et al. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..
[44] Vilmundur Gudnason,et al. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .
[45] D. Angiolillo,et al. Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome , 2011, Circulation.
[46] K. Kos,et al. SPARC: a key player in the pathologies associated with obesity and diabetes , 2010, Nature Reviews Endocrinology.
[47] Anthony J. Muslin,et al. MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. , 2008, Clinical science.
[48] Claudio Napoli,et al. Rethinking primary prevention of atherosclerosis-related diseases. , 2006, Circulation.
[49] F. Logerfo,et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. , 1999, Diabetes.